Global Infusion Therapy Devices Market 2024-2028

List of Tables

Infusion Therapy Devices Market 2024-2028

The infusion therapy devices market is forecasted to grow by USD 21.18 bn during 2023-2028, accelerating at a CAGR of 8.37% during the forecast period. The report on the infusion therapy devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, surging use of infusion therapy devices in home care settings, and growing demand for parenteral nutrition.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.45%
CAGR	8.37%
Incremental Value	$21.18bn

Technavio's infusion therapy devices market is segmented as below:

By End-user

Hospitals
Homecare settings
Clinics and ASCs

By Product

Infusion pumps
Consumables
accessories

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of smart infusion therapy devices as one of the prime reasons driving the infusion therapy devices market growth during the next few years. Also, robust growth of healthcare industry and increasing investment by vendors in R and D will lead to sizable demand in the market.

The report on the infusion therapy devices market covers the following areas:

Infusion therapy devices market sizing
Infusion therapy devices market forecast
Infusion therapy devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading infusion therapy devices market vendors that include Ace medical, AngioDynamics Inc., Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Company, Canafusion Technologies Inc., Cardinal Health Inc., Chemyx Inc., ERENLER MEDIKAL SAN. TIC. LTD. STI., Fresenius SE and Co. KGaA, ICU Medical Inc., IRadimed Corp., Medtronic, Poly Medicure Ltd., Smith and Nephew plc, Tekni Plex Inc., Teleflex Inc., Terumo Corp., and Vygon SAS. Also, the infusion therapy devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR77697

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Global infusion therapy devices market 2018 - 2022
4.2 End-user Segment Analysis 2018 - 2022
4.3 Product Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by End-user

6.1 Market segments
6.2 Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
6.4 Homecare settings - Market size and forecast 2023-2028
6.5 Clinics and ASCs - Market size and forecast 2023-2028
6.6 Market opportunity by End-user

7 Market Segmentation by Product

7.1 Market segments
7.2 Comparison by Product
7.3 Infusion pumps - Market size and forecast 2023-2028
7.4 Consumables and accessories - Market size and forecast 2023-2028
7.5 Market opportunity by Product

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 Germany - Market size and forecast 2023-2028
9.9 Japan - Market size and forecast 2023-2028
9.10 China - Market size and forecast 2023-2028
9.11 UK - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 AngioDynamics Inc.
12.4 B.Braun SE
12.5 Baxter International Inc.
12.6 Becton Dickinson and Company
12.7 Cardinal Health Inc.
12.8 Fresenius SE and Co. KGaA
12.9 ICU Medical Inc.
12.10 IRadimed Corp.
12.11 Medtronic
12.12 Poly Medicure Ltd.
12.13 Smith and Nephew plc
12.14 Tekni Plex Inc.
12.15 Teleflex Inc.
12.16 Terumo Corp.
12.17 Vygon SAS

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations